Paul Lammers
Direktor/Vorstandsmitglied bei SALARIUS PHARMACEUTICALS, INC.
Vermögen: 857 $ am 30.04.2024
Aktive Positionen von Paul Lammers
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SALARIUS PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 19.07.2019 | - |
Independent Dir/Board Member | 19.07.2019 | - | |
ImmunoMet Therapeutics, Inc.
ImmunoMet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImmunoMet Therapeutics, Inc. operates as a development-stage biopharmaceutical company that develops and commercializes novel oncology products. It offers novel technology that designed to disrupt cancer cell growth and enhance anti-cancer immunity. The company was founded in July 2015 and is headquartered in Houston, TX. | Direktor/Vorstandsmitglied | 28.11.2017 | - |
Triumvira Immunologics, Inc.
Triumvira Immunologics, Inc. Pharmaceuticals: MajorHealth Technology Triumvira Immunologics, Inc. develops and manufactures pharmaceutical products. The company was founded by Jonathan Bramson in 2015 and is headquartered in Hamilton, Canada. | Direktor/Vorstandsmitglied | 01.01.2018 | - |
Vorstandsvorsitzender | 01.01.2018 | - | |
Präsident | 01.01.2018 | - | |
Triumvira Immunologics USA, Inc.
Triumvira Immunologics USA, Inc. Miscellaneous Commercial ServicesCommercial Services Triumvira Immunologics USA, Inc. develops and manufactures novel T cell therapies for cancer. The company is based in Austin, TX and has subsidiaries in Canada. Paul Lammers has been the CEO of the company since 2018. | Direktor/Vorstandsmitglied | 01.01.2018 | - |
Vorstandsvorsitzender | 01.01.2018 | - | |
Präsident | 01.01.2018 | 24.10.2022 |
Karriereverlauf von Paul Lammers
Ehemalige bekannte Positionen von Paul Lammers
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Mirna Therapeutics, Inc.
Mirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Mirna Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of microRNA-based oncology therapeutics. Its products includes miR-34, miR-215, miR-101, miR-16, and let-7. The company was founded Matthew M. Winkler in 2007 and is headquartered in Austin, TX. | Direktor/Vorstandsmitglied | 01.11.2009 | 01.08.2017 |
Vorstandsvorsitzender | 01.11.2009 | 01.08.2017 | |
Präsident | 01.11.2009 | 01.08.2017 | |
REPROS THERAPEUTICS INC | Präsident | 23.02.2009 | 28.10.2009 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2002 | 01.09.2008 |
Ausbildung von Paul Lammers
Radboud University Nijmegen | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 7 |
Niederlande | 2 |
Kanada | 2 |
Operativ
Director/Board Member | 5 |
President | 4 |
Chief Executive Officer | 3 |
Sektoral
Health Technology | 6 |
Commercial Services | 3 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SALARIUS PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 6 |
---|---|
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
Repros Therapeutics, Inc.
Repros Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Repros Therapeutics, Inc. is a development stage biopharmaceutical company, which focuses on the development of drugs to treat hormonal and reproductive systems disorders. Its products include Enclomiphene and Proellex. The company was founded on August 20, 1987 and is headquartered in The Woodlands, TX. | Health Technology |
Mirna Therapeutics, Inc.
Mirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Mirna Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of microRNA-based oncology therapeutics. Its products includes miR-34, miR-215, miR-101, miR-16, and let-7. The company was founded Matthew M. Winkler in 2007 and is headquartered in Austin, TX. | Commercial Services |
ImmunoMet Therapeutics, Inc.
ImmunoMet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImmunoMet Therapeutics, Inc. operates as a development-stage biopharmaceutical company that develops and commercializes novel oncology products. It offers novel technology that designed to disrupt cancer cell growth and enhance anti-cancer immunity. The company was founded in July 2015 and is headquartered in Houston, TX. | Health Technology |
Triumvira Immunologics, Inc.
Triumvira Immunologics, Inc. Pharmaceuticals: MajorHealth Technology Triumvira Immunologics, Inc. develops and manufactures pharmaceutical products. The company was founded by Jonathan Bramson in 2015 and is headquartered in Hamilton, Canada. | Health Technology |
Triumvira Immunologics USA, Inc.
Triumvira Immunologics USA, Inc. Miscellaneous Commercial ServicesCommercial Services Triumvira Immunologics USA, Inc. develops and manufactures novel T cell therapies for cancer. The company is based in Austin, TX and has subsidiaries in Canada. Paul Lammers has been the CEO of the company since 2018. | Commercial Services |
- Börse
- Insiders
- Paul Lammers
- Erfahrung